[1] |
Ergun Y,Bal O,Dogan M,et al. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?[J]. J Res Med Sci,2020,25:14.
|
[2] |
Arhin ND,Shen C,Bailey CE,et al. Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients[J]. Cancer Med,2021,10(13):4269-4281.
|
[3] |
Pędziwiatr M,Mizera M,Witowski J,et al. Primary tumor resection in stage Ⅳ unresectable colorectal cancer:what has changed?[J]. Med Oncol,2017,34(12):188.
|
[4] |
Yun JA,Huh JW,Park YA,et al. The Role of Palliative Resection for Asymptomatic Primary Tumor in Patients With Unresectable Stage Ⅳ Colorectal Cancer[J]. Dise Colon Rectum,2014,57(9):1049-1058.
|
[5] |
Ha GW,Kim JH,Lee MR. Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage Ⅳ colorectal cancer in the era of modern systemic chemotherapy[J]. Ann Surg Treat Res,2018,95(2):64-72.
|
[6] |
Moher D,Liberati A,Tetzlaff J,et al. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement[J]. PLoS Med,2009,6(7):e1000097.
|
[7] |
Lo CK,Mertz D,Loeb M. Newcastle-Ottawa Scale:comparing reviewers' to authors' assessments[J]. BMC Med Res Methodol,2014,14:45.
|
[8] |
Jadad AR,Moore RA,Carroll D,et al. Assessing the quality of reports of randomized clinical trials:is blinding necessary?[J]. Control Clin Trials,1996,17(1):1-12.
|
[9] |
Parmar MK,Torri V,Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints[J]. Stat Med,1998,17(24):2815-2834.
|
[10] |
Higgins JP,Thompson SG,Deeks JJ,et al. Measuring inconsistency in meta-analyses[J]. BMJ,2003,327(7414):557-560.
|
[11] |
Patsopoulos NA,Evangelou E,Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis:proposed metrics and empirical evaluation[J]. Int J Epidemiol,2008,37(5):1148-1157.
|
[12] |
Duval S,Tweedie R. Trim and fill:A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis[J]. Biometrics,2000,56(2):455-463.
|
[13] |
Egger M,Davey Smith G,Schneider M,et al. Bias in meta-analysis detected by a simple,graphical test[J]. BMJ,1997,315(7109):629-634.
|
[14] |
Sutton AJ,Duval SJ,Tweedie RL,et al. Empirical assessment of effect of publication bias on meta-analyses[J]. BMJ,2000,320(7249):1574-1577.
|
[15] |
Kanemitsu Y,Shitara K,Mizusawa J,et al. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic,Synchronous Unresectable Metastases(JCOG1007;iPACS):A Randomized Clinical Trial[J]. J Clin Oncol,2021,39(10):1098-1107.
|
[16] |
Huang M,Yang Y,Li Q,et al. Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases[J]. Front Oncol,2022,12:747124.
|
[17] |
Park EJ,Baek JH,Choi GS,et al. The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic,Synchronous,Unresectable Metastasis:A Multicenter Randomized Controlled Trial[J]. Cancers,2020,12(8):2306.
|
[18] |
Ferrand F,Malka D,Bourredjem A,et al. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy:results from the multicenter,randomised trial Fédération Francophone de Cancérologie Digestive 9601[J]. Eur J Cancer,2013,49(1):90-97.
|
[19] |
Rahbari NN,Lordick F,Fink C,et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases(UICC stage Ⅳ):SYNCHRONOUS--a randomised controlled multicentre trial(ISRCTN30964555)[J]. BMC Cancer,2012,12:142.
|
[20] |
Samalavicius NE,Dulskas A,Baltruskeviciene E,et al. Asymptomatic primary tumour in incurable metastatic colorectal cancer:is there a role for surgical resection prior to systematic therapy or not?[J]. Wideochir Inne Tech Maloinwazyjne,2016,11(4):274-282.
|
[21] |
Watanabe A,Yamazaki K,Kinugasa Y,et al. Influence of primary tumor resection on survival in asymptomatic patients with incurable stage Ⅳ colorectal cancer[J]. Int J Clin Oncol,2014,19(6):1037-1042.
|
[22] |
Doah KY,Shin US,Jeon BH,et al. The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases[J]. Ann Coloproctol,2021,37(2):94-100.
|
[23] |
Matsumoto T,Hasegawa S,Matsumoto S,et al. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor[J]. Dis Colon Rectum,2014,57(6):679-686.
|
[24] |
Tappenden P,Jones R,Paisley S,et al. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer[J]. Health Technol Assess,2007,11(12):1-128,iii-iv.
|
[25] |
Golfinopoulos V,Salanti G,Pavlidis N,et al. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer:a meta-analysis[J]. Lancet Oncol,2007,8(10):898-911.
|
[26] |
Hochster HS,Hart LL,Ramanathan RK,et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study[J]. J Clin Oncol,2008,26(21):3523-3529.
|
[27] |
邵永孚,吴铁成. 无法治愈的结直肠癌的姑息性外科治疗[J/CD]. 中华普外科手术学杂志(电子版),2010,4(01):25-27.
|
[28] |
Simillis C,Kalakouti E,Afxentiou T,et al. Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer:A Systematic Review and Meta-analysis[J]. World J Surg,2019,43(7):1829-1840.
|
[29] |
Lee KC,Ou YC,Hu WH,et al. Meta-analysis of outcomes of patients with stage Ⅳ colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection[J]. Onco Targets Ther,2016,9:7059-7069.
|
[30] |
Ha GW,Kim JH,Lee MR. Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage Ⅳ colorectal cancer in the era of modern systemic chemotherapy[J]. Ann Surg Treat Res,2018,95(2):64-72.
|